Laboratory of Behavioural Neurobiology, Federal Institute of Technology Zurich, Schorenstrasse 16, Schwerzenbach, Switzerland.
Psychopharmacology (Berl). 2009 Nov;206(4):603-21. doi: 10.1007/s00213-009-1514-7. Epub 2009 Mar 27.
A sensitized dopamine system may be linked to the genesis of psychotic symptoms in schizophrenia. Following withdrawal from amphetamine exposures, psychotic-like traits have been robustly demonstrated, but the presence of cognitive/mnemonic deficits remains uncertain.
Adult male Lewis and Fischer rats, differing in cognitive performance, were exposed intermittently to escalating doses of amphetamine over 5 weeks. This was effective in producing behavioral sensitization to a subsequent amphetamine challenge. Following 27 days of drug withdrawal, the animals were assessed in Pavlovian conditioning, object recognition, and spatial working memory. In addition, prepulse inhibition (PPI), spontaneous motor activity, and anxiety-like behavior were measured.
Amphetamine pretreatment induced behavioral sensitization in both rat strains similarly. Working memory was enhanced in Fischer but not Lewis rats following withdrawal. Spontaneous novel object preference was enhanced in sensitized Fischer rats, but was impaired in sensitized Lewis rats, thus effectively reversing the strain difference in non-sensitized controls. In contrast, Pavlovian fear conditioning remained unaffected and so were anxiety-like behavior, open field activity, and PPI.
The face validity of the amphetamine withdrawal model for cognitive deficits was limited to the object recognition memory impairment observed in sensitized Lewis rats. Yet, the possibility that enhancing dopaminergic neurotransmission may facilitate object recognition and spatial working memory performance was demonstrated in sensitized Fischer rats. Identification of the mechanisms underlying such strain-dependent effects would be instrumental in the further specifications of the construct validity, and therefore the limitations and potential of the amphetamine sensitization model of schizophrenia.
敏化的多巴胺系统可能与精神分裂症的精神病症状的发生有关。在戒断安非他命暴露后,已经强有力地证明了类似精神病的特征,但认知/记忆缺陷的存在仍然不确定。
成年雄性刘易斯和费希尔大鼠,在认知表现上存在差异,间歇性地暴露于 5 周的递增剂量的安非他命中。这有效地产生了对随后的安非他命挑战的行为敏化。在 27 天的药物戒断后,对动物进行了巴甫洛夫条件反射、物体识别和空间工作记忆评估。此外,还测量了预脉冲抑制(PPI)、自发运动活动和焦虑样行为。
安非他命预处理在两种大鼠品系中同样诱导了行为敏化。在戒断后,工作记忆在费希尔大鼠中增强,但在刘易斯大鼠中没有增强。在敏化的费希尔大鼠中,自发新颖物体偏好增强,但在敏化的刘易斯大鼠中受损,从而有效地逆转了非敏化对照中的品系差异。相比之下,巴甫洛夫恐惧条件反射不受影响,焦虑样行为、旷场活动和 PPI 也是如此。
安非他命戒断模型对认知缺陷的表面有效性仅限于在敏化的刘易斯大鼠中观察到的物体识别记忆损伤。然而,增强多巴胺能神经传递可能有助于敏化的费希尔大鼠的物体识别和空间工作记忆表现。鉴定这种品系依赖性效应的机制将有助于进一步规范安非他命敏化模型的结构有效性,以及因此精神分裂症的局限性和潜力。